Using a new tool to support decisions for patients with ischemic heart disease
Clinical Implementation of a Novel Decision Support Tool in Patients With Ischemic Heart Disease
This study tests whether a new software tool can help doctors make better treatment decisions for patients with ischemic heart disease and improve their chances of staying out of the hospital.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 8000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Rigshospitalet, Denmark Academic / other |
| Locations | 1 site (Copenhagen Ø) |
| Trial ID | NCT06033014 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the PM-Heart algorithm, a software designed to predict survival prognosis for patients hospitalized with ischemic heart disease after undergoing coronary arteriography. The algorithm serves as a clinical decision support system, enhancing physicians' therapeutic considerations without dictating specific actions. The study aims to determine if using this algorithm improves patient outcomes and reduces the risk of re-hospitalization compared to standard treatment without the algorithm's input.
Who should consider this trial
Good fit: Ideal candidates include hospitalized patients with ischemic heart disease who have significant coronary artery lesions identified during coronary angiography.
Not a fit: Patients under 18 years of age or those living outside Denmark may not benefit from this study.
Why it matters
Potential benefit: If successful, this tool could lead to better patient outcomes and reduced hospital readmissions for those with ischemic heart disease.
How similar studies have performed: Other studies have shown promise in using decision support tools in clinical settings, suggesting potential for success with this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Hospitalized patients in one of the involved departments of cardiology (see below) with; * Ischemic heart disease; the clinical presentation may be stable, worsening/unstable angina, non-ST-elevation myocardial infarction or ST-elevation myocardial infarction, and with - Significant coronary artery lesions or diffuse coronary artery disease on invasive coronary angiography during the admission Exclusion Criteria: * \<18 years of age * Living outside Denmark
Where this trial is running
Copenhagen Ø
- Department of Cardiology, The Heart Centre, Rigshospitalet Copenhagen University Hospital. — Copenhagen Ø, Denmark (Recruiting)
Study contacts
- Study coordinator: Henning Bundgaard, Professor
- Email: henning.bundgaard@regionh.dk
- Phone: +4535450512
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.